Difference between revisions of "NET of unknown primary"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "))]" to ")]") |
|||
| Line 23: | Line 23: | ||
[[Category:NET of unknown primary regimens]] | [[Category:NET of unknown primary regimens]] | ||
[[Category:Site-agnostic regimens]] | [[Category:Site-agnostic regimens]] | ||
| + | [[Category:Malignant solid neoplasm]] | ||
Revision as of 23:51, 11 January 2020
0 regimens on this page
0 variants on this page
|
Guidelines
ESMO
- 2015: Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up PubMed
NCCN
All lines of therapy
- Poorly differentiated or small cell tumors can be treated with small cell lung cancer regimens.
- Moderate to well-differentiated neuroendocrine tumors can be treated with regimens for neuroendocrine tumors.